Radiotherapy and Radiopharmaceuticals for the Treatment of Pancreatic Neuroendocrine Tumors

Lowell B. Anthony; Partha Sinha

doi:10.1007/978-1-4939-1798-3_10

Radiotherapy and Radiopharmaceuticals for the Treatment of Pancreatic Neuroendocrine Tumors

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are typically slow growing tumors of the endocrine pancreas and are often functional. They express somatostatin receptors, and the feasibility of imaging such tumors using radioiodinated somatostatin analogs in 1989 by Krenning et al. led to the exploration of the possibilities to not only develop further imaging agents but also to develop therapeutic agents.

Original language	English
Title of host publication	Management of Pancreatic Neuroendocrine Tumors
Pages	127-134
Number of pages	8
ISBN (Electronic)	9781493917983
DOIs	https://doi.org/10.1007/978-1-4939-1798-3_10
State	Published - Jan 1 2014

Bibliographical note

Publisher Copyright:
© Springer Science+Business Media New York 2015.

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4939-1798-3_10

Cite this

@inbook{e3ba052674604dd4a19441459dabce8e,

title = "Radiotherapy and Radiopharmaceuticals for the Treatment of Pancreatic Neuroendocrine Tumors",

abstract = "Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are typically slow growing tumors of the endocrine pancreas and are often functional. They express somatostatin receptors, and the feasibility of imaging such tumors using radioiodinated somatostatin analogs in 1989 by Krenning et al. led to the exploration of the possibilities to not only develop further imaging agents but also to develop therapeutic agents.",

author = "Anthony, \{Lowell B.\} and Partha Sinha",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2015.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1798-3\_10",

language = "English",

isbn = "9781493917976",

pages = "127--134",

booktitle = "Management of Pancreatic Neuroendocrine Tumors",

}

TY - CHAP

T1 - Radiotherapy and Radiopharmaceuticals for the Treatment of Pancreatic Neuroendocrine Tumors

AU - Anthony, Lowell B.

AU - Sinha, Partha

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are typically slow growing tumors of the endocrine pancreas and are often functional. They express somatostatin receptors, and the feasibility of imaging such tumors using radioiodinated somatostatin analogs in 1989 by Krenning et al. led to the exploration of the possibilities to not only develop further imaging agents but also to develop therapeutic agents.

AB - Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are typically slow growing tumors of the endocrine pancreas and are often functional. They express somatostatin receptors, and the feasibility of imaging such tumors using radioiodinated somatostatin analogs in 1989 by Krenning et al. led to the exploration of the possibilities to not only develop further imaging agents but also to develop therapeutic agents.

UR - http://www.scopus.com/inward/record.url?scp=105010481505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=105010481505&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1798-3_10

DO - 10.1007/978-1-4939-1798-3_10

M3 - Chapter

AN - SCOPUS:105010481505

SN - 9781493917976

SP - 127

EP - 134

BT - Management of Pancreatic Neuroendocrine Tumors

ER -

Radiotherapy and Radiopharmaceuticals for the Treatment of Pancreatic Neuroendocrine Tumors

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this